Welcome to our dedicated page for Churchill Capital X SEC filings (Ticker: CCCXU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Churchill Capital Corp X (CCCXU) provides direct access to the company’s regulatory disclosures as a Nasdaq-listed blank check company. Churchill X files reports with the U.S. Securities and Exchange Commission that describe its SPAC structure, unit composition, governance changes and its proposed business combination with ColdQuanta, Inc. (Infleqtion).
Key documents for CCCXU include Current Reports on Form 8-K that outline material events. For example, a Form 8-K dated July 2, 2025 details the commencement of separate trading for the units, Class A ordinary shares (CCCX) and warrants (CCCXW), including the warrant exercise terms. Another Form 8-K dated September 8, 2025 summarizes the Agreement and Plan of Merger and Reorganization with Infleqtion, the planned domestication from the Cayman Islands to Delaware, the intended name change to "Infleqtion, Inc." and the conditions required to close the Transactions.
Through this page, users can review Churchill X’s registration statement on Form S-4 and related proxy statement/prospectus once filed and declared effective. These filings explain the proposed issuance of securities in the business combination, shareholder voting matters, risk factors and detailed descriptions of Infleqtion’s business. Additional filings may include periodic reports and further 8-Ks documenting board changes, director compensation agreements and other governance matters.
Stock Titan enhances access to these filings with AI-powered tools that summarize lengthy documents, highlight key sections such as transaction structure, closing conditions and dilution mechanics, and help users quickly locate information on unit terms, warrant features and the domestication process. Investors can also use this page to monitor any future Forms 4 or other ownership-related filings that may be associated with Churchill X’s directors, officers or sponsor entities as they are reported to EDGAR in real time.
Churchill Capital Corp X/Cayman filed an initial Form 3 for Ilan Hart, who serves as Chief Financial Officer. This filing identifies Hart as a reporting person for the company’s securities and establishes his status for future insider ownership and trading disclosures. The data provided does not list any specific share holdings or transactions.
Churchill Capital Corp X/Cayman executive Pranav Gokhale, the company’s Chief Technology Officer, has filed an initial ownership report on Form 3. This filing establishes his status as an insider for reporting purposes. The document does not report any stock transactions or specific share holdings.
Churchill Capital Corp X/Cayman filed an initial insider ownership report for Matthew John Kinsella, who serves as both a director and Chief Executive Officer. This Form 3 establishes his status as an insider of the company. The provided data shows no insider share transactions reported at this time.
Citadel-affiliated investment entities report a minority stake in Churchill Capital Corp X’s Class A ordinary shares. Citadel Securities LLC and related entities may be deemed to beneficially own 780,669 Shares, while Citadel Advisors–affiliated entities may be deemed to beneficially own 841,990 Shares.
Kenneth Griffin may be deemed to beneficially own a total of 1,622,659 Shares, representing 3.9% of the class, based on 41,700,000 Shares outstanding as of November 12, 2025. All reported positions carry shared, and no sole, voting and dispositive power. The reporting persons certify the holdings are not for the purpose of changing or influencing control of the company.
Infleqtion, Inc. reported that entities associated with sponsor Churchill Sponsor X LLC indirectly acquired 10,650,000 shares of common stock on February 12, 2026 through a conversion of Class B ordinary shares following its business combination with Legacy Infleqtion.
The filing explains that Churchill Capital Corp X was domesticated from the Cayman Islands to Delaware, and its Class B and Class A shares automatically converted into Infleqtion common stock on a one-to-one basis. Churchill Sponsor X LLC now indirectly holds these common shares and 75,000 warrants, while Michael Klein and related entities disclaim beneficial ownership beyond their pecuniary interests.
Infleqtion, Inc. received an updated ownership report from Churchill Sponsor X LLC, M. Klein Associates, Inc., and Michael Klein following the completion of a domestication and merger in mid-February 2026. The group reports beneficial ownership of 10,725,000 Infleqtion common shares, representing 4.9% of the class.
This amount includes 10,650,000 shares of common stock and 75,000 shares underlying private placement warrants, which become exercisable 30 days after completion of the mergers. The filing is labeled as Amendment No. 2 and described as a final, “exit” amendment to their prior Schedule 13D.
Churchill Capital Corp X/Cayman investors Empyrean Capital Partners and Amos Meron report that they no longer own any Class A ordinary shares of the company. In this amended Schedule 13G, they state beneficial ownership of 0 shares, representing 0% of the class, with no voting or dispositive power.
The filing confirms the securities had been held in the ordinary course of business and not for the purpose of changing or influencing control of Churchill Capital Corp X. Both parties certify the accuracy of these disclosures as of the reported ownership date.
Infleqtion, Inc. has completed its business combination with SPAC Churchill Capital Corp X, converting from a Cayman entity into a Delaware corporation and emerging as a publicly traded quantum technology company. Legacy Infleqtion stockholders received an aggregate 151,804,988 shares of common stock, implying a $1.8 billion equity value at a deemed $10.00 per share.
The deal included a PIPE financing in which investors purchased 12,654,760 shares of common stock for $126.5 million. Immediately after closing, the company had 216,471,927 shares outstanding, with Legacy Infleqtion holders owning 70.1%, Churchill public shareholders 19.1%, the sponsor 5.0% and PIPE investors 5.8%.
Churchill’s former shareholders now hold 24.0% of the company, and Churchill ceased to be a shell company. The combined company will trade on the NYSE under the symbols INFQ and INFQ WS, has adopted new charter documents, board committees and compensation plans, and implemented 2026 equity incentive and employee stock purchase plans.
Infleqtion, Inc. (formerly Churchill Capital Corp X) has filed a Form 25 to remove the listing and registration of its securities from The Nasdaq Stock Market LLC under Section 12(b) of the Securities Exchange Act of 1934.
The filing covers the company’s units (each consisting of one Class A ordinary share and one-quarter of one redeemable warrant), its Class A ordinary shares with a par value of $0.0001 per share, and its warrants, where each whole warrant is exercisable for one Class A ordinary share at an exercise price of $11.50. The notification is signed on behalf of the company by Chief Executive Officer Matthew Kinsella.
Churchill Capital Corp X reported that its shareholders overwhelmingly approved its proposed business combination with Infleqtion, Inc., a quantum sensing and quantum computing company. More than 90% of votes cast supported the deal and related proposals at the extraordinary shareholder meeting.
Redemptions were minimal: holders of 37,821 Class A shares, about 0.09% of the class, redeemed for a pro rata $388,453.90, or roughly $10.27 per share. As a result, the transaction is expected to deliver about $551.4 million of gross proceeds to Infleqtion, including approximately $424.8 million from the trust account and $126.5 million from a previously announced private placement.
Churchill will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. The combined company’s common stock and warrants are expected to trade on the NYSE under the symbols “INFQ” and “INFQ WS,” with closing of the transaction targeted for February 13, 2026, subject to customary conditions and NYSE listing requirements.